SCHEDULE OF WARRANT ACTIVITY (Details) - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Equity [Abstract] | ||
| Shares Underlying Warrants Outstanding, Beginning balance | 722,761 | |
| Weighted Average Exercise Price, Beginning balance | $ 51.04 | |
| Weighted Average Remaining Contractual Life (in years) | 3 years | 3 years 5 months 8 days |
| Shares Underlying Warrants Granted | 4,928,427 | |
| Weighted Average Exercise Price Granted | $ 6.66 | |
| Shares Underlying Warrants Exercised | (178,200) | |
| Weighted Average Exercise Price Exercised | $ 6.19 | |
| Shares Underlying Warrants Expired | (19,112) | |
| Weighted Average Exercise Price Expired | $ 964.48 | |
| Shares Underlying Warrants Outstanding, Ending balance | 5,453,876 | 722,761 |
| Weighted Average Exercise Price, Ending balance | $ 7.35 | $ 51.04 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non option equity instruments exercised in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments expirations in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments grants in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average contractual term 2. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|